Abraxis Bioscience announced the appointment of Rick Rodgers as Senior Vice President and Chief Financial Officer, succeeding David O'Toole. Rodgers most recently was Senior Vice President, Controller and Chief Accounting Officer of MGI Pharma until the company's acquisition by the Eisai Corporation in 2008.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Compelling solutions through strategic partnerships
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
